Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
Artz
M A
MA
Nephrology Department, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
Boots
J M M
JM
Ligtenberg
G
G
Roodnat
J I
JI
Christiaans
M H L
MH
Hené
R J
RJ
Blom
H J
HJ
Demacker
P N M
PN
Hilbrands
L B
LB
D016572:Cyclosporine / Q000009:adverse effects*; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D008055:Lipids; D008074:Lipoproteins; D006710:Homocysteine; D016572:Cyclosporine; D016559:Tacrolimus